Hologic (HOLX) Tops Q4 EPS by 61c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2021
November 1, 2021 4:01 PM EDTRevenue of $1.317 Billion Exceeds Expectations
Company Posts GAAP Diluted EPS of $1.28, Non-GAAP Diluted EPS of $1.61
Financial Guidance for Fiscal 2022 Anticipates Solid Growth in Core Womens Health Businesses and Continued Contributions to COVID-19 Fight
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Companys financial results for the fiscal fourth quarter ended September 25, 2021.
Our excellent top- and bottom-line results in the fourth quarter of fiscal 2021 exceeded expectations and capped off a remarkable year, said Steve MacMillan, the Companys chairman,... More
